임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
35건 표시
- 3상모집 예정· Opioid Consumption, PostoperativeAssessing Suzetrigine for Pain Reduction Following Ureteroscopic Surgery
협력: 버텍스
- 2상모집 중· Myasthenia Gravis, GeneralizedA Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
리드: 버텍스
- 1상모집 중단 (진행 중)· PainEffects of Efavirenz on the Pharmacokinetics of Suzetrigine in Healthy Participants
리드: 버텍스
- 1상모집 중· Cystic FibrosisDose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants
리드: 버텍스
- 1상모집 중· Cystic FibrosisDose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants
리드: 버텍스
- 3상모집 중· Diabetic Peripheral Neuropathic PainEvaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
리드: 버텍스
- 2상모집 중· Autosomal Dominant Polycystic Kidney Disease (ADPKD)Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)
리드: 버텍스
- 2/3상모집 중· Primary Membranous NephropathyEvaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
리드: 버텍스
- 2상초청 등록· Myotonic Dystrophy Type 1 (DM1)A Study of Long-term Safety and Efficacy of VX-670 in Participants With Myotonic Dystrophy Type I
리드: 버텍스
- 2상모집 중단 (진행 중)· Proteinuric Kidney DiseaseInaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities
리드: 버텍스
- 단계 미표기모집 중단 (진행 중)· Autosomal Dominant Polycystic Kidney Disease (ADPKD)Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease
리드: 버텍스
- 3상모집 중단 (진행 중)· Diabetic Peripheral Neuropathic PainEvaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN)
리드: 버텍스
- 3상모집 중단 (진행 중)· Cystic FibrosisEvaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis Participants 12 Months of Age and Older
리드: 버텍스
- 2상모집 중· Diabetic Peripheral Neuropathic PainEvaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
리드: 버텍스
- 3상모집 중· Diabetic Peripheral Neuropathic PainEvaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
리드: 버텍스
- 1/2상모집 중· Myotonic Dystrophy Type 1 (DM1)A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)
리드: 버텍스
- 1상모집 중단 (진행 중)· Cystic FibrosisEvaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis
리드: 버텍스
- 1/2상모집 중단 (진행 중)· Type 1 DiabetesA Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes
리드: 버텍스
- 1/2상모집 중단 (진행 중)· Cystic FibrosisA Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)
리드: 버텍스
- 3상모집 중단 (진행 중)· Cystic FibrosisStudy to Evaluate Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) Long-term Safety and Efficacy in Subjects Without F508del
리드: 버텍스
- 3상모집 중단 (진행 중)· Cystic FibrosisA Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy
리드: 버텍스
- 3상모집 중단 (진행 중)· Cystic FibrosisEvaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age
리드: 버텍스
- 3상모집 중단 (진행 중)· Beta-ThalassemiaEvaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)
리드: 버텍스
- 3상모집 중단 (진행 중)· Sickle Cell DiseaseEvaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)
리드: 버텍스
- 2/3상모집 중· Proteinuric Kidney DiseasePhase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
리드: 버텍스
- 3상모집 중· Diabetes Mellitus, Type 1A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
리드: 버텍스
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.